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ABSTRACT
This study shows that lack of ovarian activity has a negative impact on the life 
span of female mice. The extent to which this phenomenon could be associated with 
the anti-inflammatory effect of estrogens was analyzed in metabolic organs and aorta, 
by quantitative analysis of mRNAs encoding proteins in the inflammatory cascade. 
We demonstrate that the TNFα, IL-1β, MCP-1, MIP-2 and IL-6 mRNA contents are 
increased in the liver, adipose tissue and aorta 7 months after ovariectomy (ovx) 
and this increased basal inflammation is maintained as the mice aged. In contrast, 
the extent of inflammatory gene expression is directly proportional to age in sham-
operated mice. As a consequence, at 22 months, most of the inflammatory parameters 
examined were higher in the sham-operated group compared with the ovx group. 
These observations led us to propose that the decreased longevity of ovx mice may be 
due to an acceleration of the basal state of inflammation in metabolic organs, which 
is likely driven by the combination of a lack of estrogen-mediated anti-inflammatory 
activity and the loss of gonadal control of energy metabolism.
INTRODUCTION
In an effort to limit the major societal burden of 
pathologies associated with human aging, recent research 
has focused on improving our understanding of the 
mechanisms regulating senescence and longevity. Cellular, 
animal and clinical studies led to a number of theories on 
the mechanistic underpinnings of aging [1–4]. Among 
those theories, the impairment of metabolic functions and 
deficits within the defense immune system are gaining 
increasing consideration [1, 5]. The metabolic and immune 
systems are closely associated [5], and a deregulated 
immune response may damage the activity of metabolic 
organs [6]. In contrast, unbalanced energy metabolism is 
a trigger for inflammatory processes [7]. Thus, the two 
systems may cooperate to create an unhealthy vicious 
cycle that accelerates senescence and decreases longevity.
A parsimonious use of energy prolongs life span by 
decreasing the probabilities of damage to the pathways 
controlling nutritional and internal energy deposits. 
In line with this view, reproduction, which ultimately 
requires energy, favors aging and reduces longevity [8]. 
Indeed, aging is inextricably linked to different aspects of 
reproduction in many species. For instance, the removal of 
germ cells is associated with a longer life-span in a large 
variety of oviparous, including worms, flies, insects, fishes 
and in male mammals [8–13]. In contrast, initial studies 
in female mammals (rats) indicated that ovx is associated 
with a shortened life span [14] and that the pathological 
deficiency or loss of ovarian function is associated with 
the derangement of energy metabolism and immune 
function (rodents and humans) [15]. These data suggest 
that the ovaries and their endocrine activity may have 
a positive effect on longevity in mammals. Supporting 
this theory, Nurse’s Health study [16] reported that 
women had greater longevity after elective hysterectomy 
compared with those who received ovariectomy and 
hysterectomy. In addition, menopause is associated with 
metabolic dysfunction [15] and pathologies involving 
inflammation (e.g., osteoporosis and metabolic disorders, 
including diabetes, atherosclerosis, joint diseases and even 
neurodegeneration) [5, 17].
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Estrogens regulate energy metabolism in several 
organs, including the liver, where these hormones 
strongly influence lipid and cholesterol metabolism [18, 
19]. In fact, ovx in mice and menopause in women are 
associated with increased weight, decreased lean mass 
[20], visceral fat (vWAT) accumulation [21] and an 
increase of lipids in the liver. These changes may initiate 
a complex chain of events, where the formation of lipid 
deposits (e.g., in hepatocytes and adipocytes) induces 
macrophage recruitment and activation [6], resulting in an 
inflammatory state that intensifies metabolic dysfunctions 
and lipid deposition and worsens the inflammatory status 
[22, 23]. In addition, estrogens are anti-inflammatory 
molecules [24–26]. Thus, considering that generalized 
low-grade inflammation is a major factor in determining 
senescence [5], the loss of ovarian estrogens in aging 
females may aggravate the senescence process via an 
increase in generalized inflammation.
The aim of this study was to investigate the extent 
to which the loss of ovarian activity affects the production 
of proinflammatory mediators during aging. Because of 
the synergic, negative interplay between inflammation 
and energy metabolism, our study initially focused on two 
major metabolic organs: the liver and adipose tissue. We 
also investigated the aorta as a primary target of alterations 
in lipid metabolism and inflammatory processes. Our 
results indicate that ovx carried out in adult mice 
accelerates the accumulation of a number of products in the 
inflammatory cascade that are characteristic of aging in the 
liver, adipocytes and aorta. Importantly, ovx was associated 
with a significantly decrease in life span, suggesting that 
the ovx-dependent acceleration of aging was dependent on 
increased basal inflammation and may have detrimental 
consequences for the health of female mice.
RESULTS
Survival after ovariectomy
To evaluate the effect of ovx on inflammation, 
female mice were subjected to sham-operation or ovx 
at 5 months of age. The age of surgery was selected to 
assess the effect of ovary loss in mature, adult mice. The 
animals (10 per experimental group) were generated in 10 
harems, randomized at the beginning of the experiment 
and exposed to the same environmental conditions 
throughout the study, as surgery and aging were carried 
out in our departmental facilities. Periodic vaginal smears 
(every 3 weeks) indicated that the sham-operated mice 
were cycling up to approximately 18 months. By 22 
months, the cycles ceased, and the production of ovarian 
hormones was decreased, as indicated by uterus weight 
(Supplementary Figure 1). Competitive risk analysis for 
death (Figure 1a) demonstrated that the probability of 
death was significantly higher in the ovx group compared 
with the age-matched, sham-operated controls. This 
Figure 1: Gonadectomy and life span in female and male mice. (a) Female PPRE-lucRepTOP™ were gonadectomized (OVX, 
n = 40) or sham-operated (SHAM, n = 40) at 5 months of age. Each group was randomly subdivided into 4 clusters of 10 animals each to 
be euthanized at 6, 12, 18 and 22 month of age to evaluate the state of inflammation. Predicted cumulative incidence curves for death by 
natural causes in SHAM and OVX animals were calculated as described in the methodology section. The risk of death by natural causes was 
significantly higher in ovx mice compared with sham-operated mice (p < 0.05). (b) Male ERE-LucRepTOP™ in the C57BL/6J background 
were orchiectomized (n = 40) or sham operated (n = 40) at 5 month of age. 20 animals from each group were euthanized at 6 months and 
20 months, respectively. Data are expressed as the mean % survival ± SEM.
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phenomenon was sex-specific because the survival rate 
of male mice orchiectomized (orx) at 5 months was 35% 
compared with 10% in the sham-operated mice at 20 
months (Figure 1b). To evaluate the reproducibility of the 
effect of ovx on female survival, we analyzed the results 
of another study carried out using similar experimental 
conditions to those described in the Figure 1a, except 
the mice had slightly different genetic backgrounds 
and were maintained in a commercial breeding facility 
(see Experimental Procedures section). This study also 
indicated that ovx mice had a higher probability of death 
than sham-operated mice (P = 0.005 with Grey’s test) 
(data not shown). Therefore, gonadectomy had a positive 
effect on male, but not female, mouse longevity.
Ovx accelerates the inflammatory process 
associated with aging
Increased basal inflammation is strictly associated 
with senescence [5]. Thus, we measured mRNAs 
encoding proinflammatory cytokines and chemokines in 
2 major metabolic organs, the liver and white adipose 
tissue (perigonadal and abdominal, vWAT) [5]. We also 
studied the aorta as a primary target of alterations in lipid 
metabolism and inflammatory processes in female aging 
[27]. All cycling mice were euthanized at metestrus to 
prevent variability in the expression of inflammatory genes 
due to fluctuating levels of circulating sex hormones in the 
reproductive cycle. The mRNAs encoding tumor necrosis 
factor-α (TNFα), interleukin-1β (IL1β), macrophage 
chemoattractant protein-1 (MCP-1), macrophage 
inflammatory protein-2 (MIP-2) and interleukin-6 (IL-6) 
were measured by quantitative rtPCR in tissue extracts. 
In sham-operated mice, the mRNAs encoding these pro-
inflammatory mediators increased steadily with age, and 
at 22 months, the mRNAs investigated were significantly 
higher than at 6 months (Figure 2a). In the ovx mice, the 
effect of age was not as obvious; the accumulation of 
inflammatory precursors was higher than in the sham-
operated group at 12 months, and the relatively high 
expression of these mRNAs did not increase with aging (in 
some cases they diminished, e.g., MCP-1) (Supplementary 
Figure 2). The effect of ovx was significant when we 
expressed the level of each inflammatory mediator as 
a percent of the respective sham-operated age group 
(Figure 2b); generally, the amount of inflammatory mRNA 
accumulated in the ovx mice was significantly higher 
than that in the sham-operated mice at approximately 
12 months of age, and with few exceptions, the content 
of inflammatory products in the tissues of ovx mice was 
significantly lower in the sham-operated group than in 
the ovx group by 22 months. Thus, ovx accelerated the 
age-associated accumulation of inflammatory molecules. 
Interestingly, this effect required several months (6–7) to 
become significant, suggesting that the mere absence of the 
anti-inflammatory action of circulating estrogens was not 
sufficient to impair the homeostasis of the inflammatory 
system. These data led us to hypothesize that the effect 
of ovx was initially minor, but became significant when 
associated with the functional alterations of the immune 
system that occur with aging.
The effect of short- and long-term ovariectomy 
on inflammation in adipocytes
To test the hypothesis above, we investigated 
the effect of ovx in very young animals. Surgery (sham 
or ovx) was performed at 1 month, immediately after 
the first estrous cycle, (long-term ovx, LT-OVX) or 
4 months (short-term ovx, ST-OVX), and all mice were 
euthanized at 5 months. TNFα, IL1β, MCP-1, MIP-2 and 
IL-6 mRNAs were measured in the vWAT using rtPCR. 
Figure 3a shows that LT-OVX, but not ST-OVX, 
significantly augmented TNFα, IL1β, MCP-1 and IL-6 
compared with the sham-operated counterpart. Remarkably, 
TNFα mRNA only was significantly augmented 
by LT-OVX in the liver (Supplementary Figure 3). 
These results led us to hypothesize that, at least in 
vWAT, the delayed effect of ovx on the accumulation of 
inflammatory molecules was the result of a mild activation 
of the native immune system due to decreased circulating 
estrogens; this subtle immune deficiency required 
months to manifest. The lack of marked, significant 
inflammation in the liver suggested that, in younger 
mice, this organ could cope better than vWAT with lower 
levels of circulating sex hormones. To further investigate 
the consequences of ovx in vWAT, we measured the 
markers, F4/80 (as a general marker of macrophages) 
and CD11c (indicator of M1 state of polarization), in 
ST-OVX and LT-OVX [28–30]. Figure 3b illustrates 
that both of these markers were significantly increased 
in the LT-OVX group. However, when we analyzed the 
percentage of activated macrophages (CD11c versus 
F4/80 mRNA), we also observed a significant change in 
the ST-OVX group, suggesting that ovx was associated 
with a rapid change in macrophage activation and caused 
macrophage recruitment in vWAT. The deficiency of 
circulating estrogens might favor the slow accumulation 
of inflammatory products. In LT-OVX mice vWAT, we 
observed a significant enlargement of adipocytes (Figure 
3c), suggesting that ovx was also associated with impaired 
adipocyte homeostasis.
These alterations of fat metabolism in association 
with ovx were predictable, as previous studies have 
demonstrated that liver lipid metabolism is highly 
modified by the loss of ovarian functions [19]. 
Furthermore, we found that ovx affected animal weight. 
Figure 4a demonstrates that the ovx mice weighed 
significantly more than did the sham-operated at 12 
months, but their weight did not continue to increase 
with age. In contrast, weight increased progressively in 
sham-operated mice. A quantitative analysis of 
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macrophage markers revealed that there was a continuous, 
progressive increase in both F4/80 and CD11c in sham-
operated animals, and this increase became significant at 
22 months. In contrast, the expression of these markers 
was significantly higher in the ovx group at 6–12 months 
of age compared with the sham-operated group, but at 
22 months, it was lower than the age-matched controls. 
Interestingly, CD11c expression was increased in the 
6-month group at one month after ovx; this was not 
observed in younger animals, suggesting an accrued 
sensitivity to an inflammatory stimulus (ovx) at 5 months 
of age (Figure 4b). The comparative analysis of the 
expression of F4/80 and CD11c in sham and ovx mice 
clearly indicated that ovx mice have an accelerated 
inflammatory response that fades over time (Figure 4c).
Is ovx affecting FoxP3+ regulatory T cell 
accumulation in vWAT?
To evaluate whether ovx affected other functions 
of the immune response, we investigated the response of 
Foxp3 T regulatory cells (Treg). Tregs are a) important 
guardians of the immune response and highly involved 
in the regulation of the metabolic consequences of 
inflammation [31] and b) modulated by estrogens [32]. 
Foxp3 mRNA was measured by rtPCR, and we used the 
lineage-specific marker, Foxp3, and a pan-marker gene for 
T cells, CD3, to determine the proportion of the Treg cell 
sub-population . Similar to the ovx group, Foxp3 mRNA 
increased during the course of aging in vWAT (Figure 4d); 
however, when we compared the Foxp3 expression in the 
Figure 2: Effects of aging and ovariectomy on the basal state of inflammation in metabolic organs and the aorta. (a) 
Tissues from sham operated mice collected in Figure 1 were stored until rtPCR analysis. Data are expressed as the mean ± SEM and 
were analyzed by one-way ANOVA, followed by Bonferroni post hoc test. °P < 0.05; °°P < 0.01, °°°P < 0.001 vs. 6 months; *P < 0.05. 
**P < 0.01, ***P < 0.001 vs. 12 months. #P < 0.05; ##P < 0.01, ###P < 0.001 vs. 18 months. (b) Data represent the percent change of 
ovx vs. sham operated mice. Statistical significance was determined by comparing the raw numbers of ovx and sham-operated mice using 
unpaired t-tests. °P < 0.05; °°P < 0.01, °°°P < 0.001 ovx vs. sham. The experiment was repeated with a second cohort of aged ovx and 
sham-operated mice with superimposable results.
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two groups, the content of Treg mRNA in ovx mice was 
progressively lower than in sham-operated counterparts 
with aging, indicating an incremental impairment in the 
ability of the immune system to suppress the inflammatory 
response associated with aging and ovx. Several studies 
demonstrated that Foxp3+ Treg cells might be derived 
from the recruitment of circulating Treg cells and through 
the conversion of resident T cells or in loco clonal 
Figure 3: Effect of short- and long-term ovx in vWAT. Sham-operated female C57BL/6J mice at metestrus (n = 8) and 1 month 
(ST-OVX; n = 8) or 4 months (LT-OVX; n = 8) after ovx were euthanized at 5 months of age, and vWAT was rapidly removed and snap 
frozen for further analysis. (a) rtPCR was used to measure cytokine and chemokine mRNA content in vWAT. (b) Expression of markers 
for macrophages (F4/80) or macrophage M1 polarization (CD11c) were measured by rtPCR in vWAT. (c) Top panel: Representative images 
of H&E staining of vWAT tissues from sham-operated, ST-OVX and LT-OVX mice. Bottom panel: graphs represent the quantification 
of adipocyte size obtained using the Adiposoft ImageJ software. Data are expressed as the mean ± SEM and were analyzed by one-
way ANOVA, followed by Bonferroni’s post hoc test. °P < 0.05; °°P < 0.01; °°°P < 0.001 vs. sham-operated. *P < 0.05; **P < 0.01; 
***P < 0.001 vs. ST-OVX. #P < 0.05 vs. sham-operated, as determined by unpaired t-test.
Oncotarget6www.impactjournals.com/oncotarget
Figure 4: Expression of immune response markers in the vWAT of sham-operated and ovx aging mice. (a) The body 
weight of each mouse was measured before euthanasia. Data were analyzed by two-way ANOVA, followed by Bonferroni’s post hoc test. 
°P < 0.05; °°P < 0.01; and °°°P < 0.001 vs. 6 months of age; *P < 0.05 vs. 12 months of age; #P < 0.05 vs. age-matched sham operated. 
(b) F4/80 and CD11c mRNA contents were measured using rtPCR of tissue extracts from the vWAT of sham-operated and ovx female 
mice. °°°P < 0.001 vs. 6 months of age; #P < 0.05; ##P < 0.01; and ###P < 0.001 ovx vs. sham. Data were analyzed by two-way ANOVA, 
followed by Bonferroni’s post hoc test. (c) Macrophage activation in vWAT was expressed as the ratio of CD11c to F4/80 mRNA content. 
Statistical analysis was performed by comparing the raw numbers from ovx and sham-operated mice by two-way ANOVA, followed 
by Bonferroni’s post hoc test. §P < 0.05; §§P < 0.01; and §§§P < 0.001. (d) The F4/80 and CD11c mRNA content of ovx mice are 
shown as the percentage of the mean of the sham-operated mice of the same age. Data were analyzed by two-way ANOVA, followed by 
Bonferroni’s post hoc test. °°°P < 0.001 vs. 6 months of age. (e) Treg content in vWAT was expressed as the ratio of Foxp3 to CD3 mRNA 
levels. The Foxp3/CD3 ratio of ovx mice was represented as a percentage of the mean of sham-operated mice of the same age. Data were 
analyzed by two-way ANOVA, followed by Bonferroni’s post hoc test. No statistical significance was found. All data are expressed as the 
mean ± SEM. Analysis of markers of immunity and body weight was repeated in separate aging experiments with superimposable results.
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expansion in vWAT and non-lymphoid tissues. Therefore, 
we verified whether aging and ovx affected the amount 
of Foxp3+ Treg cells in the spleen, a lymphoid organ 
rich in these cells. The data in Supplementary Figure 4 
demonstrate that Foxp3/CD3 mRNA did not increase with 
aging in the spleens of either sham or ovx mice, indicating 
that these variations occur selectively in vWAT.
DISCUSSION
The present study indicates that removing the 
gonads in adult female mice is associated with decreased 
longevity and acceleration of the age-dependent 
progression of basal inflammation.
Ovariectomy accelerates the age-dependent 
progression of basal inflammation
The negative effect of ovx on life span in female 
mammals is well documented [14, 16], but the mechanisms 
involved in this process are poorly understood. Here, we 
report that ovx accelerates age-dependent progression 
of basal inflammation. The extent to which ovx affects 
the immune system either directly, by diminishing the 
efficiency of the inflammatory processes, or indirectly, by 
altering energy homeostasis and inducing a metabolically 
driven, chronic, low-grade inflammation that plays a 
crucial role in aging, remains unknown.
Estrogens are natural anti-inflammatory agents 
[24–26], and the lack of ovarian-mediated production of 
these sex hormones leads to the excessive accumulation 
of inflammatory molecules. Ovx is also associated with 
the rapid alteration of lipid metabolism and increased 
lipid deposits in the liver [19]. The accumulation of fat 
triggers the following physiological effects: i.) increased 
mitochondrial β-oxidation and the production of reactive 
oxygen species with insufficient suppression of lipolysis 
and ii.) the recruitment and activation of macrophages that 
initiate the secretion of proinflammatory factors in both 
fat and the liver. In lean individuals, small adipocytes 
promote metabolic homeostasis, whereas enlarged 
adipocytes recruit macrophages [6], promote inflammation 
[33] and release a range of factors that predispose toward 
metabolic diseases in obese individuals (e.g., insulin 
resistance) [34]. Studies comparing the responses of male 
and female mice to obesity and high-fat diet indicated that 
there was less immune cell infiltration and oxidative stress 
in the adipose tissue of females [35], indicating that high 
levels of circulating estrogens represent a protective factor 
against the inflammatory reactions induced by the stress 
pathways involved in energy metabolism.
The fact that an augmented inflammatory status 
is observed at 6–7 months after ovx did not allow us to 
draw definitive conclusions regarding the main target of 
estrogen that provides its beneficial effect, but it is possible 
to envisage a scenario in which a.) the alteration of energy 
homeostasis requires time to significantly affect energy 
deposits and trigger low-grade inflammation and b.) the 
lack of estrogens impairs macrophage activity, which 
significantly increases the accumulation of inflammatory 
molecules.
CD11c expression was increased relative to F4/80 1 
month after ovx, suggesting that macrophages are rapidly 
activated in the vWAT after ovx. These data indicate that 
fat macrophages play a role in the increased inflammation 
observed at later times after ovx. The involvement of the 
Treg system in quenching the immune reaction does not 
appear to be a key element for suppressing the response to 
ovx. Indeed, as soon as 1 month after ovx, Treg cells are 
enriched in the T cell population in fat, but this response 
is not sufficient to counteract macrophage activation. 
Furthermore, the number of Foxp3 cells appears to 
decrease with time after ovx. In contrast, we observed 
that the number of Foxp3+ cells increased with aging in 
mice bearing intact ovaries, indicating that this system 
continuously attempts to limit the extent of inflammation 
induced by the senescent organism.
Several studies have described the effects of 
aging on circulating cytokines and demonstrated that 
inflammatory markers are significant predictors of 
mortality in old humans [7], but the extent to which 
inflammation is a cause or a consequence of aging 
remains unclear. However, only a handful of publications 
have investigated the modulation of cytokine production 
in metabolic organs, such as the vWAT and the liver, 
during physiological aging, and even fewer studies have 
investigated the effects of female aging and the lack of 
ovarian hormones on basal inflammation in these organs. 
This study fills this knowledge gap by demonstrating that 
ovx accelerates basal inflammation and shortens the life 
span. We propose that the ovx-induced acceleration of 
generalized inflammation represent the cause, or simply 
an indicator, of early damage precipitating the senescence 
process that, once induced, progresses with time, 
independently of the inflammatory system; at 22 months, 
ovx mice had lower basal inflammation than did sham 
mice, but the former’s survival was significantly reduced.
Reproduction and longevity are not negatively 
correlated
Our observation that removing the gonads in adult 
female mice decreases longevity contradicts previous 
investigations, suggesting that a trade-off exists between 
the activity of the reproductive system and longevity, 
whereby the lack of reproduction or the ablation of 
reproductive organs is associated with a longer life span 
[36]. Most prior studies on this subject utilized oviparous 
species and male mammals. Confirming previous studies, 
orx was not associated with diminished life span in males 
in our study, but studying the aging of female mice with 
identical genetic backgrounds that were reared in the same 
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environmental condition revealed a sex-specific effect of 
gonadal ablation in mammals.
In oviparous, all of the nutrients stored in the egg 
that are essential for the development and growth of the 
embryo are produced by metabolic organs (primarily by 
the liver and, in less evolved animals, organs with hepatic 
functions) upon gonadal stimulation. This reciprocal 
control between gonads and the liver represents a 
simple, but extremely efficacious, means to prevent the 
unnecessary synthesis of energy molecules during gonadal 
malfunction and the blockage of reproductive functions 
when the energy supply is low.
In mammals, the production of a fertile egg represents 
only the initial step in reproduction. Once fertilized, the egg 
requires a growing supply of energy from the mother to 
ensure its development as an embryo and its maturation after 
birth. It is foreseeable that this change in the reproductive 
strategy caused a major revision in the liver-gonads dualistic 
control at each stage of fertility (puberty, pregnancy, 
lactation, and phases of the reproductive cycle), which 
require very different metabolic activities. Thus, evolution 
must have selected females in which the mechanism 
governing energy homeostasis had the flexibility necessary 
to adapt to these highly mutable requirements. Therefore, 
it is conceivable that with placentation, female metabolism 
diverged significantly from the ancestral system. Of course, 
mammalian males were not affected by these changes and 
maintained the ancestral mechanisms controlling energy 
metabolism; this may explain why there is a significant 
dimorphism in the physiology of energy metabolism 
in mammals and why the inverse relationship between 
longevity and reproduction was maintained from nematodes 
to humans in males, but not females.
The hypothesis that gonadal hormones have 
acquired significant control over the activities of metabolic 
organs in female mammals is rooted in significant 
experimental evidence demonstrating that estrogens have a 
major influence on glucose [37] and lipid [19] metabolism 
and clinical data showing that pathological and age-related 
ovarian dysfunction are closely associated with alterations 
in energy metabolism. Indeed, estrogens appear to play 
a key function in the signaling between reproductive 
and metabolic systems in mammals, including humans 
[15, 19, 38]; experimental and clinical evidence indicates 
that the loss of ovarian function in women at menopause 
is associated with the onset of an atherogenic lipid profile 
[39], which increases the risk of cardiovascular disease 
[40, 41] and a number of pathologies characterized by a 
significant inflammatory component.
METHODS
Animals
All mice used were bred on the C57BL/6 
background. For the aging experiments, we used 
transgenic strains engineered to follow via in vivo imaging 
the activity of intracellular receptors. In the experiment 
shown in Figure 1a, PPRE-lucRepTOP™ (TOP srl, Lodi, 
Milan, Italy) in C57BL/6J was obtained from the original 
C57Bl/6xDBA/2 F2 through over 21 backcrossings. The 
males shown in Figure 1b and the females used to repeat 
the aging experiment contained ERE-LucRepTOP™ (TOP 
srl, Lodi, Milan, Italy) in C57BL/6J background.
To limit any genetic, environmental or rearing 
effects, all mice were born during the same period of 
time by trio breeding (one male and two females). All 
littermates were randomly distributed among the different 
experimental groups. The size of each experimental group 
was dictated by the sensibility of our assays. For aging 
experiments, each experimental group was composed of 
10 mice, and the groups contained 8 mice for all other 
experiments. Mice were bred in our Departmental facilities 
and at Harlan commercial facilities (Corezzana, Italy). 
Mice were housed in ventilated plastic cages (335 cm2 
floor area and 13 cm height) with hardwood chip bedding, 
and the animals were provided filtered water ad libitum. 
The number of animals/cage never exceeded 4. The 
animal room was maintained within a temperature range 
of 22–25°C, with an automatic 12 h light-dark cycle (lights 
on at 0700 h). The mice were maintained on a standard, 
estrogen-free diet (Mucedola 4RF21) (https://www.google.
it/?gws_rd=ssl#hl=it&q=Mucedola+4RF21) and were 
moved to a certified estrogen-free diet 1 week before the 
experiment (AIN93M, Mucedola, Settimo Milanese, Italy) 
(http://www.zeiglerfeed.com/product_literature/lab%20
research%20literature_Research/Purified%20Rodent%20
Diet%20AIN-93M.pdf).
For ovx, the mice were anesthetized with a 50 μl 
s.c. injection of a ketamine (93.6 mg/kg, Ketavet 100; 
Intervet, Milan, Italy) and xylazine (7.2 mg/kg, Rompun; 
Bayer, Milan, Italy) solution and were then subjected to 
ovx or sham surgery. In the aging experiment, mice were 
subjected to ovx at 5 months of age, and in the experiment 
reported in Figure 3, mice were subjected to ovx at 
1 month, after the first estrous cycle. As reported in the 
literature [42], vaginal opening occurs at day 28.1± 2.0 in 
wild type C57Bl/6 mice, when they weigh an average of 
14.6 grams. Trained technicians performed the surgeries, 
and we achieved 100% success, as demonstrated by 
both vaginal smears and uterus weight at the end of the 
experimentation.
At the indicated time points (6–12–18–22 months 
for the aging experiment and 5 months for the ST/LT OVX 
experiment), mice were anesthetized using ketamine (93.6 
mg/kg, Ketavet 100; Intervet, Milan, Italy) and xylazine 
(7.2 mg/kg, Rompun; Bayer, Milan, Italy) and euthanized 
by cervical dislocation. The liver, vWAT and aorta were 
quickly excised, snap frozen in dry ice and stored at 
−80°C for subsequent gene expression analysis. Portions 
of the vWAT (from the experiment in Figure 3) were fixed 
in 4% paraformaldehyde for 24 h and then embedded in 
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paraffin. Sham-operated mice were all euthanized in the 
same phase of the estrous cycle, metestrus.
During the reproductive cycle of the sham-operated 
mice, the phase of the cycle was assessed by blind analysis 
of dry mount of vaginal smears stained using the May-
Grünwald-Giemsa method (MGG Quick Stain Kit; Bio-
Optica, Milan, Italy), according to the manufacturer’s 
protocol. During the aging experiment, smears were 
collected for one week at three-week intervals. Mice were 
defined as cycling when at least a proestrus was observed 
during a 1-week period.
Ethics statement
Investigation has been conducted in accordance with 
the ethical standards and according to the Declaration of 
Helsinki and according to the Guide for the Care and Use 
of Laboratory Animals, as adopted and promulgated by 
the US National Institute of Health, and in accordance 
with the European Guidelines for Animal Care and Use 
of Experimental Animals. In addition, the experiments 
were approved by the Italian Ministry of Research 
and University and controlled by a panel of experts at 
the Department of Pharmacological and Biomolecular 
Sciences (University of Milan, Milan, Italy).
Real-time PCR gene expression analysis
The vWAT, liver and aorta were homogenized in 
TRIzol® (Life Technologies, Carlsbad, CA), (6% w/v 
vWAT and liver, and 16% w/v aorta) using a TissueLyser 
(QIAGEN, Milan, Italy), and RNA was purified using the 
RNeasy MiniKit (QIAGEN, Milan, Italy), according to the 
manufacturer’s instructions. To prepare the cDNA, 1 μg 
of RNA was denatured at 75°C for 5 min in the presence 
of 1.5 μg of random primers in a 15 μl final volume. 
Deoxynucleotide triphosphate and Moloney murine 
leukemia virus reverse transcriptase were added at final 
concentrations of 0.5 mM and 8 U/μl, respectively, in a 
final volume of 25 μl. The RT reaction was performed at 
37°C for 1 h, and the enzyme was inactivated at 75°C for 
5 min. Control reactions without the addition of the RT 
enzyme were performed using 20% of the samples.
The RT-PCR experiments were performed using 
TaqMan technology and TaqMan Gene Expression Assays 
(Life Technologies, Carlsbad, CA, USA) to analyze mouse 
TNFα (Mm00443258_m1), IL-1β (Mm00434228_m1), 
macrophage chemoattractant protein-1 (MCP1; 
Mm00441242_m1), macrophage inflammatory protein-2 
(MIP2; Mm00436450_m1), IL-6 (Mm00446190_m1), 
F4/80 (Mm00802529_m1), CD11c (Mm00498698_m1), 
CD3 (Mm005996484_g1) and Foxp3 (Mm00475162_
g1). We used the 18SrRNAVIC-MGB PDAR (Life 
Technologies, Carlsbad, CA, USA) as a reference for all 
of the assays.
The reactions were carried out according to the 
manufacturer’s protocol using a 7900HT fast real-time 
PCR system (Applied Biosystems Inc., Foster City, CA, 
USA), and the data were analyzed by using the 2-ΔΔCt 
method [43].
For Foxp3 expression analysis, tissues were 
homogenized in 1 ml of PureZol RNA isolation reagent 
(Bio-Rad, Hercules, CA, USA), according to the 
manufacturer’s instructions, using GentleMACS and 
GentleMACS M Tubes (Miltenyi Biotec GmbH, Bergisch 
Gladbach, Germany). Retrotranscription was performed 
using a High Capacity cDNA Reverse Transcription 
kit (Applied Biosystems Inc., Foster City, CA, USA). 
Relative gene expression was calculated using Rn18s 
(Mm03928990_g1) as an endogenous control, and all 
samples were normalized to the mean relative mRNA 
expression of the sham group.
Determination of adipocyte size
Five-micrometer-thick sections of paraffin-
embedded vWAT were stained with Mayer’s Hematoxylin 
and Eosin (H&E). Images of the staining were captured 
at X2000 magnification using a Zeiss Axioscope 
microscope equipped with a digital camera (Carl Zeiss, 
Thornwood, NY). Adipocyte area and average diameter 
were determined using Adiposoft, a software program 
that utilizes the NIH’s open-share Fiji program (http://
sw.wikkii.com/wiki/Adiposoft). Macros were developed 
to determine which cells to include in the size calculations 
(they had to be above a certain level of circularity and 
size to exclude pre-adipocytes or other cell types), and 
the area and Feret’s diameter were calculated for each 
adipocyte assigned to each animal. For each mouse, 25–35 
adipocytes from three separate sections were analyzed to 
determine the mean adipocyte volume.
Statistical analysis
Unless otherwise stated, statistical significance 
was assessed by ANOVA using Bonferroni’s multiple 
comparison post hoc test, using GraphPad Prism 5 
(GraphPad Software, San Diego, CA).
For aging experiments, the mice were sacrificed at 
6 month interval, so death from “natural causes”, which is 
the focus of our survival analysis, could not be observed 
for all mice. The death due to sacrifice of mice represents 
a competitor to death from natural causes; thus, these 
parameters were analyzed using methods appropriate for the 
competing risks framework (cumulative incidence analysis). 
The risk of failing from natural death in the presence of a 
competing event (sacrifice due to experimental design) (crude 
cumulative incidence) was evaluated by the method proposed 
by Prentice. Crude cumulative incidence curves were 
compared by Gray test [44], which is an extension of log-rank 
test. To this end, competing risk analysis was performed using 
the statistical software R with the add-on package “cmprsk” 
(CumIncidence function), as described by [45].
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CONCLUSIONS
The present study underlines the uniqueness of 
female physiology and the relevance of ovarian function 
for longevity. Additionally, these findings underscore the 
necessity of rigorous studies on sexual dimorphisms for 
the generation of pharmacological and hormonal therapies 
that are tailored to female patho-physiology.
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